If you liked this article you might like

Week in Review: Nasdaq Brushes Aside Trump-Triggered Selloff in Biotech
Trump's Remarks Show Why Pharma Sector Is 'Barely Investable': More Squawk From Jim Cramer
Stocks at Session Lows as Tech, Drugmaker Names Sell Off
Drug Stocks Find Trump Animus a Bitter Pill